The weekly litigation news digest is live. Subscribe now

IP Verse

Stable Pharmaceutical Composition For Oral Administration - EP3318259

The patent EP3318259 was granted to Astellas Pharma on Jan 11, 2023. The application was filed on Jul 1, 2016 under application number EP16821324A. The patent is currently recorded with a legal status of "Revoked".

EP3318259

ASTELLAS PHARMA
Application Number
EP16821324A
Filing Date
Jul 1, 2016
Status
Revoked
Sep 26, 2025
Publication Date
Jan 11, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
GENERICS UKOct 11, 2023ELKINGTON AND FIFEADMISSIBLE
SANDOZOct 10, 2023KRAUS & LEDERER PARTGMBBADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTJP2014501770
INTERNATIONAL-SEARCH-REPORTWO2010128659
INTERNATIONAL-SEARCH-REPORTWO2015119122
OPPOSITIONEP2428508
OPPOSITIONUS2013273161
OPPOSITIONUS8969336
OPPOSITIONUS9755832
OPPOSITIONWO2010128659
OPPOSITIONWO2015119122
SEARCHEP2428508
SEARCHJP2014501770
SEARCHUS2013273161
SEARCHWO2010128659
SEARCHWO2015119122

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents